Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro.
about
Adenosine receptors as therapeutic targetsAdenosine signaling and function in glial cellsLinks between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humansOverexpression of UCP2 protects thalamic neurons following global ischemia in the mouse.Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in miceDecreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia.Adenosine kinase determines the degree of brain injury after ischemic stroke in mice.Purines and the Anti-Epileptic Actions of Ketogenic Diets.Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury.Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.Investigating the mechanisms underlying neuronal death in ischemia using in vitro oxygen-glucose deprivation: potential involvement of protein SUMOylation.Targeting astrocytes for stroke therapy.The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects.Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury.Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation.Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.
P2860
Q24632095-7988F09A-D6BA-4FA9-B2ED-AE97A9F736C0Q24634273-6223CFA8-61B4-47A4-81F3-A6D5F0A7F696Q30428503-83CD7F75-A231-427A-AC1B-78940AC64330Q33321139-02C7ECAA-FC6E-4A6E-A2ED-60439F185756Q34147890-9C57BF64-C212-4E9E-878A-234E776BA799Q34599971-B6BEF21F-A5FB-47ED-A2AA-6FF76234F6C1Q35108543-D161902F-7983-44D3-8B26-AF535193E4E2Q35513799-A1D63702-7E58-4232-A512-969C02A181D5Q36568447-51275D3A-4351-4610-B823-9CE27B1643DDQ37206467-F36670A4-241B-4143-B5A4-416D2A9F8294Q37333353-2FEBF6B4-E5FD-4276-BA21-DDDFF9A2A0F2Q37794392-2030A000-2588-41A7-B10B-6B9F804274D3Q37852727-D387CEE9-2F01-44C5-BF20-7B3E3C13769FQ42594826-363D61CE-2557-4C10-8632-A50C89D8E21DQ46668123-255A65C5-0BE0-4884-801A-9CA692AB453CQ46693610-8AA366E8-FE4A-4B32-BCF1-D3AE0DA23DBFQ47674396-848C2F59-2699-4A44-BC2E-F36244512268
P2860
Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@ast
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@en
type
label
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@ast
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@en
prefLabel
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@ast
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@en
P2093
P2860
P1476
Deletion of the adenosine A1 r ...... ischaemia in vivo or in vitro.
@en
P2093
Anna Rytter
Bertil B Fredholm
Fredrik Asztély
Maj-Lis Smith
Tobias Cronberg
Tomas Olsson
P2860
P304
P356
10.1111/J.1460-9568.2004.03564.X
P407
P577
2004-09-01T00:00:00Z